Published 1 day ago

GLP1-RAs and Type 1 Diabetes: A retrospective study of incretin-based therapy use with Open Source AID.

Summary by Diabettech - Diabetes and Technology | Where Diabetes and Technology Meet

So far in this series we've looked at why incretin therapy might be a useful adjunct to traditional type 1 treatment, and also how the pharmacokinetics might be best used to manage type 1. In this article, we look at the feedback from users of these treatments and some of the positives and negatives that

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated18 hours agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

GLP1-RAs and Type 1 Diabetes: A retrospective study of incretin-based therapy use with Open Source AID.

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics